Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene
- PMID: 19335919
- PMCID: PMC2667509
- DOI: 10.1186/1476-511X-8-12
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene
Abstract
There is a predominance of small and dense LDL cholesterol particles in familial combined hyperlipidemia (FCH). The lipoprotein lipase gene could exert an influence in these circumstances.To study the relationship of pattern B LDL and lipids with N291S polymorphism of lipoprotein lipase (LPL) in FCH patients.Lipid profile, apolipoproteins, diameter of LDL and N291S polymorphism were determined in 93 patients with FCH and 286 individuals from the general population.FCH patients with N291S polymorphism showed a lower mean diameter of LDL. FCH patients with pattern B LDL showed higher concentrations of triglycerides, VLDLc, non-HDLc and apo B100 and lower levels of HDLc than those with pattern A. Of FCH patients with polymorphism 87.5% presented pattern B and 12.5% pattern A, while patients without polymorphism presented pattern A in 69.2% cases and pattern B in 30.8% cases, with differences being statistically significant (p < 0.004). The prevalence of this mutation in our FCH patients was 9.7%.The prevalence of N291S mutation in our FCH patients was similar to the 9.3% described in Dutch FCHL patients but clearly higher than the 2-5% described for other Caucasian populations. No polymorphism was found in our general population sample. FCH patients with phenotype B of LDL possessed an atherogenic lipid profile. The relationship between small and dense LDL and the presence of the N291S mutation may identify patients with high cardiovascular risk.
Similar articles
-
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.Eur J Clin Invest. 1996 Aug;26(8):631-9. doi: 10.1111/j.1365-2362.1996.tb02146.x. Eur J Clin Invest. 1996. PMID: 8872057
-
Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.Atherosclerosis. 1996 Oct 25;126(2):313-24. doi: 10.1016/0021-9150(96)05924-2. Atherosclerosis. 1996. PMID: 8902157
-
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.J Lipid Res. 1996 Feb;37(2):309-19. J Lipid Res. 1996. PMID: 9026529
-
Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.Eur Heart J. 1998 Jul;19 Suppl H:H23-6. Eur Heart J. 1998. PMID: 9717061 Review.
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
Cited by
-
The genetics of familial combined hyperlipidaemia.Nat Rev Endocrinol. 2012 Feb 14;8(6):352-62. doi: 10.1038/nrendo.2012.15. Nat Rev Endocrinol. 2012. PMID: 22330738 Review.
-
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3. Biochem Genet. 2022. PMID: 34478023 Review.
References
-
- Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia and the metabolic syndrome. Am J Cardiol. 1998;81:18B–25B. - PubMed
-
- Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506. - PubMed
-
- St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25:553–559. - PubMed
-
- Eurlings PM, Kallen CJ van der, Geurts JM, van Greevenbroek MM, de Bruin TW. Genetic dissection of familial combined hyperlipidemia. Mol Genet Metab. 2001;74:98–104. - PubMed
-
- Hoffer MJV, Bredie SJH, Boomsma DI, Reymer PWA, Kastelein JJP, de Knijff P, Demacker PNM, Stalenhoef AFH, Havekes LM, Frants RR. The lipoprotein lipase (Asn291-Ser) mutation associated with elevated lipid level families with familial combined hyperlipidaemia. Atherosclerosis. 1996;119:159–167. - PubMed